Literature DB >> 6773078

Clinical pharmacokinetics of antiepileptic drugs in adults.

P L Morselli, R Franco-Morselli.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6773078     DOI： 10.1016/0163-7258(80)90009-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  11 in total

1.  Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-Davis.

Authors:  S C Olson; H Bockbrader; R A Boyd; J Cook; J R Koup; R L Lalonde; P H Siedlik; J R Powell
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

Review 2.  Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.

Authors:  Shay Matalon; Thomas A Rasmussen; Charles A Dinarello
Journal:  Mol Med       Date:  2011-03-15       Impact factor: 6.354

Review 3.  Ictal Interictal Continuum Patterns.

Authors:  Gamaleldin M Osman; Davi F Araújo; Carolina B Maciel
Journal:  Curr Treat Options Neurol       Date:  2018-04-18       Impact factor: 3.598

Review 4.  Therapeutic drug monitoring: a comprehensive and critical review of analytical methods for anticonvulsive drugs.

Authors:  A H Kumps
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

Review 5.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

6.  The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study.

Authors:  Pieter Okkerse; Guido van Amerongen; Marieke L de Kam; Jasper Stevens; Richard P Butt; Rachel Gurrell; Albert Dahan; Joop M van Gerven; Justin L Hay; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2017-01-09       Impact factor: 4.335

7.  The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro.

Authors:  Shay Matalon; Brent E Palmer; Marcel F Nold; Antonio Furlan; Afework Kassu; Gianluca Fossati; Paolo Mascagni; Charles A Dinarello
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

8.  The effect of activated dimethicone and a proprietary antacid preparation containing this agent on the absorption of phenytoin.

Authors:  J C McElnay; G Uprichard; P S Collier
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

9.  Obesity and overweight as CAE comorbidities and differential drug response modifiers.

Authors:  Ravindra Arya; Catherine W Gillespie; Avital Cnaan; Mahima Devarajan; Peggy Clark; Shlomo Shinnar; Alexander A Vinks; Kana Mizuno; Tracy A Glauser
Journal:  Neurology       Date:  2016-03-30       Impact factor: 9.910

Review 10.  Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature.

Authors:  Muhammad Atif; Muhammad Azeem; Muhammad Rehan Sarwar
Journal:  Springerplus       Date:  2016-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.